Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michał Matyjaszczyk is active.

Publication


Featured researches published by Michał Matyjaszczyk.


Frontiers in Pharmacology | 2013

Determinants of patient adherence: a review of systematic reviews.

Przemyslaw Kardas; Pawel Lewek; Michał Matyjaszczyk

Purpose: A number of potential determinants of medication non-adherence have been described so far. However, the heterogenic quality of existing publications poses the need for the use of a rigorous methodology in building a list of such determinants. The purpose of this study was a systematic review of current research on determinants of patient adherence on the basis of a recently agreed European consensus taxonomy and terminology. Methods: MEDLINE, EMBASE, CINAHL, Cochrane Library, IPA, and PsycINFO were systematically searched for systematic reviews published between 2000/01/01 and 2009/12/31 that provided determinants on non-adherence to medication. The searches were limited to reviews having adherence to medication prescribed by health professionals for outpatient as a major topic. Results: Fifty-one reviews were included in this review, covering 19 different disease categories. In these reviews, exclusively assessing non-adherence to chronic therapies, 771 individual factor items were identified, of which most were determinants of implementation, and only 47—determinants of persistence with medication. Factors with an unambiguous effect on adherence were further grouped into 8 clusters of socio-economic-related factors, 6 of healthcare team- and system-related factors, 6 of condition-related factors, 6 of therapy-related factors, and 14 of patient-related factors. The lack of standardized definitions and use of poor measurement methods resulted in many inconsistencies. Conclusions: This study provides clear evidence that medication non-adherence is affected by multiple determinants. Therefore, the prediction of non-adherence of individual patients is difficult, and suitable measurement and multifaceted interventions may be the most effective answer toward unsatisfactory adherence. The limited number of publications assessing determinants of persistence with medication, and lack of those providing determinants of adherence to short-term treatment identify areas for future research.


International Journal of Behavioral Medicine | 2015

Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence

Todd M. Ruppar; Fabienne Dobbels; Pawel Lewek; Michał Matyjaszczyk; Kaat Siebens; Sabina De Geest

BackgroundPoor adherence to medications is a significant problem that leads to increased morbidity, mortality, and health care costs. Recommended approaches to address medication adherence vary, and existing practice guidelines are unclear.PurposeThis review evaluated clinical practice guidelines designed to help health care providers address patients’ medication adherence.MethodMultiple search methods were used to identify national or international guidelines addressing medication adherence. We included guidelines published in English, as well as guidelines with an English-language summary or translation.ResultsWe identified 23 guidelines of varying detail and quality. Recommendations were categorized as assessment strategies (n = 20 guidelines); educational strategies (n = 18); behavioral strategies (n = 17); therapeutic relationship, communication, and provider factors (n = 19); and addressing outside influences/co-morbidities (n = 10).ConclusionFuture guidelines should be more clearly guided by research findings and comparative effectiveness methods. When implemented, guidelines will facilitate health care providers and health systems in supporting optimal adherence and improved health outcomes.


British Journal of Clinical Pharmacology | 2012

A new taxonomy for describing and defining adherence to medications.

Bernard Vrijens; Sabina De Geest; Dyfrig A. Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd M. Ruppar; Fabienne Dobbels; Emily Fargher; Val Morrison; Pawel Lewek; Michał Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey Aronson; John Urquhart


Psychiatria Polska | 2013

[Prevalence, reasons, and forms of use of legal highs by internet-based survey participants].

Maciej R. Mazurkiewicz; Michał Glogowski; Dobrosława Mrowińska; Marcin Pakulski; Michał Matyjaszczyk; Przemyslaw Kardas


Forum Medycyny Rodzinnej | 2015

Czy stanowisko zajmowane przez aptekarza w aptece wpływa na jego ocenę leków generycznych

Pawel Lewek; Janusz Śmigielski; Izabela Banaś; Michał Matyjaszczyk; Przemysław Kardas


Forum Medycyny Rodzinnej | 2015

Czy rodzaj apteki, w której pracuje aptekarz, wpływa na jego ocenę leków generycznych?

Pawel Lewek; Janusz Śmigielski; Michał Matyjaszczyk; Izabela Banaś; Przemysław Kardas


Forum Medycyny Rodzinnej | 2015

Co użytkownicy sądzą o e-papierosach — przegląd badań ankietowych

Pawel Lewek; Selina Mensah; Michał Matyjaszczyk; Izabela Banaś; Przemysław Kardas


Archive | 2012

Ascertaining barriers to compliance: Policies for safe, effective and cost-effective use of medicines in Europe

A. Andrzejczyk; Wendy Clyne; S. De Geest; Jenny Demonceau; Fabienne Dobbels; Emily Fargher; Dyfrig A. Hughes; Przemyslaw Kardas; Pawel Lewek; Michał Matyjaszczyk; Sarah McLachlan; Val Morrison; C. Msheila; Sahdia Parveen; A. Piaszczynska; Catrin O. Plumpton; Todd M. Ruppar; Kaat Siebens; John Urquhart; Bernard Vrijens; Simon White


Medical Science and Technology | 2009

Streptococcus pyogenes: A rare etiology of non-Gonococcic Urethritis and Balanitis – diagnostic problems in the practice of family medicine and urology – a case study

Joanna Jaczewska-Matyjaszczyk; Maciej R. Mazurkiewicz; Michał Majzner; Mariola Matyjaszczyk; Bruce Alperstein; Michał Matyjaszczyk


Medical Science and Technology | 2009

Hypertensive disorders of pregnancy, developing eclampsia – a case study

Joanna Jaczewska-Matyjaszczyk; Jan Matyjaszczyk; Bogumił Jaczewski; Piotr Okoński; Przemyslaw Kardas; Pawel Lewek; Bruce Alperstein; Michał Matyjaszczyk

Collaboration


Dive into the Michał Matyjaszczyk's collaboration.

Top Co-Authors

Avatar

Pawel Lewek

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Przemyslaw Kardas

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fabienne Dobbels

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruce Alperstein

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge